XILIO THERAPEUTICS INC. - COMMON STOCK
0.8000
13-March-25 10:38:09
15 minutes delayed
Stocks
-0.0250
-3.03%
Today's range
0.7966 - 0.8247
ISIN
N/A
Source
NASDAQ
-
Xilio Therapeutics to Present at the Citi 2023 Virtual Oncology Leadership Summit
16 Feb 2023 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day
02 Feb 2023 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Host Live Virtual Program Spotlighting XTX301, a Tumor-Activated IL-12
23 Nov 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
09 Nov 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at Cowen 6th Annual ‘IO Next’ Summit
04 Nov 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference
22 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Appoints Tomas J. Heyman to Board of Directors
15 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
06 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President
16 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at the H.C. Wainwright Global Investment Conference
18 May 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Appoints Stacey Davis as Chief Business Officer
17 May 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
12 May 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
07 Apr 2022 06:30:00 By Nasdaq GlobeNewswire
-
01 Mar 2022 06:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Participate in the Cowen 42nd Annual Healthcare Conference
28 Feb 2022 06:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics to Participate in the Guggenheim 4th Annual Oncology Day
03 Feb 2022 06:30:00 By Nasdaq GlobeNewswire
-
20 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
06 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
02 Dec 2021 07:30:00 By Nasdaq GlobeNewswire